Genetics Society of America

Belkins
The mission of the Genetics Society of America (GSA) is to deepen our understanding of the living world by advancing the field of genetics. It does this by: Fostering an international community of geneticists by promoting interaction among geneticists (including microbial, plant, animal, human, and population and theoretical geneticists) while cultivating a community of thought leaders in the field. Ensuring genetics fulfills its potential for broad impact by facilitating the application of genetic tools and approaches in biological research.

Related News

TSCAN AND NOVARTIS PARTNER TO DEVELOP CANCER THERAPIES

Pharmaceutical Technology | April 16, 2020

news image

Biopharmaceutical firm TScan Therapeutics has signed an agreement with Novartis to discover and develop therapies for the treatment of cancer. The companies aim to work on TCR-engineered T-cell therapies for solid tumours. TScan’s platform will identify cancer antigens that could be targeted by TCR-based treatments. As part of the deal, TScan will find and characterise TCRs while Novartis will hold an option to licence and develop TCRs for up to three new targets. Furthermore, Novartis wil...

Read More

US CLINICAL TRIALS OF HYDROXYCHLOROQUINE HIT WARP SPEED COULD SHOW IN WEEKS

CNBC | April 15, 2020

news image

Researchers are working as quickly as science will allow to determine whether hydroxychloroquine, a decades-old malaria drug touted by President Donald Trump as a potential “game changer” in curtailing the Covid-19 pandemic, is effective in fighting the coronavirus. Federal health regulators have fast-tracked approvals for coronavirus research, allowing scientists across the nation to skip through months of red tape on potential treatments and vaccines for the deadly virus. On March ...

Read More

RX SAVINGS SOLUTIONS ANNOUNCES EXPANSION OF PHARMACY TRANSPARENCY OFFERING TO MID-MARKET ORGANIZATIONS

Prnewswire | May 27, 2020

news image

Rx Savings Solutions announced today its entrance into the mid-market segment with the expansion of their personalized prescription drug transparency program to midsize organizations. With this comprehensive solution driven by more than 29,000 clinical recommendations, more benefit leaders of all sizes can provide a valuable resource for members to engage with personalized savings options. As pharmacy continues to be the most predictable and repeated spend in healthcare, Rx Savings Solutions aim...

Read More

POLICY AND REGULATION

EPIENDO PHARMACEUTICALS SECURES FUNDING TO ADVANCE CLINICAL DEVELOPMENT OF ITS NON-ANTIBIOTIC MACROLIDE FOR THE TREATMENT OF COPD

EpiEndo Pharmaceuticals | August 19, 2021

news image

EpiEndo Pharmaceuticals , a privately held biopharmaceutical company focused on a novel barrier enhancing approach to the treatment of chronic inflammatory airway diseases such as chronic obstructive pulmonary disease (COPD), announces the closing of a €20m Series A financing round led by Flerie Invest and Iðunn Venture Fund, with existing investors ABC Ventures participating, along with the European Innovation Council (EIC) Fund joining the round. The financing secures funds to advance...

Read More

Pharmaceutical Technology | April 16, 2020

news image

TSCAN AND NOVARTIS PARTNER TO DEVELOP CANCER THERAPIES

Biopharmaceutical firm TScan Therapeutics has signed an agreement with Novartis to discover and develop therapies for the treatment of cancer. The companies aim to work on TCR-engineered T-cell therapies for solid tumours. TScan’s platform will identify cancer antigens that could be targeted by TCR-based treatments. As part of the deal, TScan will find and characterise TCRs while Novartis will hold an option to licence and develop TCRs for up to three new targets. Furthermore, Novartis wil...

Read More

CNBC | April 15, 2020

news image

US CLINICAL TRIALS OF HYDROXYCHLOROQUINE HIT WARP SPEED COULD SHOW IN WEEKS

Researchers are working as quickly as science will allow to determine whether hydroxychloroquine, a decades-old malaria drug touted by President Donald Trump as a potential “game changer” in curtailing the Covid-19 pandemic, is effective in fighting the coronavirus. Federal health regulators have fast-tracked approvals for coronavirus research, allowing scientists across the nation to skip through months of red tape on potential treatments and vaccines for the deadly virus. On March ...

Read More

Prnewswire | May 27, 2020

news image

RX SAVINGS SOLUTIONS ANNOUNCES EXPANSION OF PHARMACY TRANSPARENCY OFFERING TO MID-MARKET ORGANIZATIONS

Rx Savings Solutions announced today its entrance into the mid-market segment with the expansion of their personalized prescription drug transparency program to midsize organizations. With this comprehensive solution driven by more than 29,000 clinical recommendations, more benefit leaders of all sizes can provide a valuable resource for members to engage with personalized savings options. As pharmacy continues to be the most predictable and repeated spend in healthcare, Rx Savings Solutions aim...

Read More

POLICY AND REGULATION

EpiEndo Pharmaceuticals | August 19, 2021

news image

EPIENDO PHARMACEUTICALS SECURES FUNDING TO ADVANCE CLINICAL DEVELOPMENT OF ITS NON-ANTIBIOTIC MACROLIDE FOR THE TREATMENT OF COPD

EpiEndo Pharmaceuticals , a privately held biopharmaceutical company focused on a novel barrier enhancing approach to the treatment of chronic inflammatory airway diseases such as chronic obstructive pulmonary disease (COPD), announces the closing of a €20m Series A financing round led by Flerie Invest and Iðunn Venture Fund, with existing investors ABC Ventures participating, along with the European Innovation Council (EIC) Fund joining the round. The financing secures funds to advance...

Read More